WRAP53 and cancer: We further evaluated telomerase activity in primary pan‐cancer samples by dividing them into heterozygous, homozygous, deletion, and no deletion (other) of the TCAB1 gene, and the result showed comparable enzyme activity among the three groups in most cancer types (21/33).